Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

XunLei Kang

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Trends in Cancer|March 8, 2024
Limited dsRNA editing impedes leukemia stem cellsYi Pan, XunLei Kang
Journal of Cellular Immunology|July 15, 2021
Ca<sup>2+</sup>/calmodulin-dependent Protein Kinases in Leukemia DevelopmentChanghao Cui, Chen Wang, Min Cao, et al.
Cell|November 6, 2007
SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxiaJinke Cheng, Xunlei Kang, Sui Zhang, et al.
Cells|December 24, 2021
The Role of T Cell Immunotherapy in Acute Myeloid LeukemiaFang Hao, Christine Sholy, Chen Wang, et al.
Frontiers in Cell and Developmental Biology|September 7, 2021
Strategy for Leukemia Treatment Targeting SHP-1,2 and SHIPFang Hao, Chen Wang, Christine Sholy, et al.
Science China. Life Sciences|November 15, 2015
Inhibitory leukocyte immunoglobulin-like receptors in cancer developmentFeiFei Zhang, JunKe Zheng, XunLei Kang, et al.
Cell Cycle (Georgetown, Tex.)|December 5, 2015
Inhibitory leukocyte immunoglobulin-like receptors: Immune checkpoint proteins and tumor sustaining factorsXunlei Kang, Jaehyup Kim, Mi Deng, et al.
Molecular Cell|April 27, 2010
SUMO-specific protease 2 is essential for suppression of polycomb group protein-mediated gene silencing during embryonic developmentXunlei Kang, Yitao Qi, Yong Zuo, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 22, 2022
Repair of Limb Ischemia Is Dependent on Hematopoietic Stem Cell Specific-SHP-1 Regulation of TGF-β1Chen Wang, Ravi Nistala, Min Cao, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2026
A Druggable Tumor Suppressor and Leukemic Stem Cell MarkerYi Pan, Xiaduo Meng, Chen Wang, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Trends in Cancer|March 8, 2024
Limited dsRNA editing impedes leukemia stem cellsYi Pan, XunLei Kang
Journal of Cellular Immunology|July 15, 2021
Ca<sup>2+</sup>/calmodulin-dependent Protein Kinases in Leukemia DevelopmentChanghao Cui, Chen Wang, Min Cao, et al.
Cell|November 6, 2007
SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxiaJinke Cheng, Xunlei Kang, Sui Zhang, et al.
Cells|December 24, 2021
The Role of T Cell Immunotherapy in Acute Myeloid LeukemiaFang Hao, Christine Sholy, Chen Wang, et al.
Frontiers in Cell and Developmental Biology|September 7, 2021
Strategy for Leukemia Treatment Targeting SHP-1,2 and SHIPFang Hao, Chen Wang, Christine Sholy, et al.
Science China. Life Sciences|November 15, 2015
Inhibitory leukocyte immunoglobulin-like receptors in cancer developmentFeiFei Zhang, JunKe Zheng, XunLei Kang, et al.
Cell Cycle (Georgetown, Tex.)|December 5, 2015
Inhibitory leukocyte immunoglobulin-like receptors: Immune checkpoint proteins and tumor sustaining factorsXunlei Kang, Jaehyup Kim, Mi Deng, et al.
Molecular Cell|April 27, 2010
SUMO-specific protease 2 is essential for suppression of polycomb group protein-mediated gene silencing during embryonic developmentXunlei Kang, Yitao Qi, Yong Zuo, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 22, 2022
Repair of Limb Ischemia Is Dependent on Hematopoietic Stem Cell Specific-SHP-1 Regulation of TGF-β1Chen Wang, Ravi Nistala, Min Cao, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2026
A Druggable Tumor Suppressor and Leukemic Stem Cell MarkerYi Pan, Xiaduo Meng, Chen Wang, et al.
Pageof 4